Nothing different. We are hovering around cash value on the contract including the payout to pip. We'll bounce to $3-$5 once pip is paid sometime this year. FDA approval and the follow on contract is where the big appreciation comes from in the future. That's about it.
I'm at essentially the same conclusion. Siga is burning on average about $6 mil a quarter and has a something over $100 mil on the books now with another $90 mil locked in and arriving over the next few months, with another $50 million or so medium term mostly in 2017, and the possibility of another $100 mil longer term for FDA approval. On top of all that there is an additional $50 mil in options that are likely but with unclear timing. PIP will get their hard earned money. SIGA will get paid when the follow on contract is announced, probably shortly after FDA approval. Chimerix is self destructing; the only thing that made brinci competitive for smallpox with st-246 no longer exists.